Citation bias favoring positive clinical trials of thrombolytics for acute ischemic stroke: a cross-sectional analysis

Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis

(2016) William N Whiteley et al.   LANCET NEUROLOGY

Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department

(2015) Michael D. Brown et al.   ANNALS OF EMERGENCY MEDICINE

The most important tasks for peer reviewers evaluating a randomized controlled trial are not congruent with the tasks most often requested by journal editors

(2015) Anthony Chauvin et al.   BMC Medicine

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015)   LANCET

Thrombolysis in acute ischaemic stroke: time for a rethink?

(2015) B. S. Alper et al.   BMJ-British Medical Journal

Thrombolysis in acute ischaemic stroke: time for a rethink?

(2015) B. S. Alper et al.   BMJ-British Medical Journal

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

(2014) Jonathan Emberson et al.   LANCET

Reputation and impact in academic careers

(2014) A. M. Petersen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Citation bias favoring statistically significant studies was present in medical research

(2013) Anne-Sophie Jannot et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

(2013) Edward C. Jauch et al.   STROKE

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

(2012)   LANCET

Reporting bias in medical research - a narrative review

(2010) Natalie McGauran et al.   Trials

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

(2008)   CEREBROVASCULAR DISEASES

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

(2008) Stephen M Davis et al.   LANCET NEUROLOGY

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study

(2008) Werner Hacke et al.   LANCET NEUROLOGY

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

(2008) Werner Hacke et al.   NEW ENGLAND JOURNAL OF MEDICINE